Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study

Modelling impact and cost‐effectiveness of oral pre‐exposure prophylaxis in 13 low‐resource countries

(2020) Carel Pretorius et al.   Journal of the International AIDS Society

Integrating oral PrEP delivery among African women in a large HIV endpoint‐driven clinical trial

(2020) Ivana Beesham et al.   Journal of the International AIDS Society

PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa

(2020) Dvora L Joseph Davey et al.   Lancet HIV

Substantial decline in use of HIV pre-exposure prophylaxis (PrEP) following introduction of COVID-19 physical distancing restrictions in Australia

(2020) Mohamed A. Hammoud et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Preexposure Prophylaxis for the Prevention of HIV Infection

(2019) Roger Chou et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Integrated provision of topical pre‐exposure prophylaxis in routine family planning services in South Africa: a non‐inferiority randomized controlled trial

(2019) Leila E Mansoor et al.   Journal of the International AIDS Society

Are 2 million bottles of PrEP an empty gesture?

(2019) The Lancet HIV   Lancet HIV

Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017

(2018) Patrick S. Sullivan et al.   ANNALS OF EPIDEMIOLOGY

Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand

(2018) Nittaya Phanuphak et al.   Sexual Health

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study

(2018) Andrew E Grulich et al.   Lancet HIV

HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project

(2017) Robyn Eakle et al.   PLOS MEDICINE

Rapidly declining HIV infection in MSM in central London

(2017) Nneka Nwokolo et al.   Lancet HIV

The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies

(2013) Gabriela B. Gomez et al.   PLOS MEDICINE

FDA paves the way for pre-exposure HIV prophylaxis

(2012) David Holmes   LANCET